Search Results 1871-1880 of 14721 for anti-TNF drugs

  1. Tedizolid (Oral Route) Description and Brand Names - Mayo Clinic

    Tedizolid is used to treat acute bacterial skin and skin structure infections (ABSSSI). It belongs to the class of drugs called antibiotics. Tedizolid works by ...

  2. Loncastuximab Tesirine in WM - Mayo Clinic

    the Second International Workshop on Waldenström macroglobulinemia. - At least 2 prior lines of treatment, including an anti-CD20 monoclonal antibody ...

  3. STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Prior therapy with immune checkpoint inhibitors (e.g., anti-CTLA4, ...

  4. SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease - Mayo Clinic

    About this study. To investigate the efficacy of the administration of JVS-100 delivered via direct intramuscular injections on a 3 month and 6 month ...

  5. Sulfamethoxazole And Trimethoprim (Oral Route) Before Using - Mayo Clinic

    Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

  6. Tofacitinib (Oral Route) Precautions - Mayo Clinic

    Precautions. Drug information provided by: Merative, Micromedex®. It is very important that your doctor check your progress at regular visits. This will ...

  7. Oncology (Medical) - Overview - Mayo Clinic

    Targeted drug therapy; Biological therapy; Chemotherapy; Hormone therapy; Supportive and Palliative Care Therapies; Experimental therapies; Other systemic ...

  8. Clonidine (Transdermal Route) Description and Brand Names - Mayo Clinic

    Clonidine belongs to the class of medicines called antihypertensives. It works in the brain to change some of the nerve impulses.

  9. Antihistamine, Decongestant, And Analgesic Combination (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  10. Stopping Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients - Mayo Clinic

    ... treatment gaps of more than 12 weeks [84 days] between any two doses). Current Anti-Asthma Therapy: Asthma is currently being treated with a controller ...